+86-15502157206
NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
Leona Raskova Kafkova, Joanna M. Mierzwicka, Prosenjit Chakraborty, Petr Jakubec, Ondrej Fischer, Jozef Skarda, Petr Maly, Milan Raska
- Time：2024;
- Target：CD11c,CD3,CD39,CD4,CD45,CD45RO,CD8,CD86,FoxP3,HLA-DR,HLA-E,ICOS,LAG3,PD-1,PD-L1,T-bet,TIM-3,Vimentin
Abstract
No content available at the moment!
Original document click
LitRelated Products
LitReview
No content available at the moment!
